Aspen Aerogels, Inc. (NYSE:ASPN) Short Interest Update

Aspen Aerogels, Inc. (NYSE:ASPN) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 9,260,000 shares, an increase of 8.8% from the October 31st total of 8,510,000 shares. Based on an average daily volume of 2,540,000 shares, the short-interest ratio is currently 3.6 days.

Aspen Aerogels Trading Up 2.8 %

Shares of NYSE ASPN traded up $0.39 during mid-day trading on Wednesday, reaching $14.21. The company had a trading volume of 907,284 shares, compared to its average volume of 1,630,052. The business’s 50-day moving average is $19.43 and its 200-day moving average is $23.73. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of 1,382.00 and a beta of 2.12. Aspen Aerogels has a 52 week low of $10.36 and a 52 week high of $33.15.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ASPN. TD Cowen increased their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Finally, Barclays cut their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Insider Activity

In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 4.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Point72 Hong Kong Ltd bought a new position in shares of Aspen Aerogels in the second quarter worth about $84,000. nVerses Capital LLC bought a new position in Aspen Aerogels during the 2nd quarter worth about $95,000. Quent Capital LLC bought a new position in Aspen Aerogels during the 3rd quarter worth about $118,000. Point72 DIFC Ltd bought a new position in Aspen Aerogels during the 2nd quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado bought a new position in Aspen Aerogels during the 2nd quarter worth about $145,000. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.